Genetic Studies to Identify Stroke Subtypes and Outcome

Completed

Phase N/A Results N/A

Summary of Purpose

This study will characterize the gene response of the body's immune and inflammatory cells to stroke. There is a wide variation in stroke risk, stroke outcome, and response to clot-busting therapy for stroke. This variation may be due to differences in people's response to injury or infection, or to differences in genetic make-up between individuals. Genes store the biological information that determines the...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 June 2017.

3 Jun 2002 26 Jul 2006 Unavailable 15 Dec 2008 15 Dec 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

  • Patient Recruitment and Public Liaison Office Phone: (800) 411-1222 Email: prpl@mail.cc.nih.gov

    prpl@mail.cc.nih.gov